Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
98.90    -1.20 (-1.20%)
Bid:
99.22
Ask:
99.28
Spread: 0.06 (0.06%)
Market Cap: £57.64b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Issue of Equity

2 Mar 2026 16:25

RNS Number : 9942U
Lloyds Banking Group PLC
02 March 2026
 

2 March 2026

 

LLOYDS BANKING GROUP PLC - NOTIFICATION OF ISSUANCE OF EQUITY SECURITIES

 

On 19 January 2026, Lloyds Banking Group plc (the "Company") announced details of its ordinary shares of 10p each ("Shares") that had been block listed under the historic UK Listing Rules block listing regime for the purposes of satisfying share plan awards and that remained unallotted as at that date (the "Unallotted Shares"). Further to that announcement, the Company announces the allotment and issuance of 220,314,633 Unallotted Shares between 19 January 2026 and 27 February 2026 (inclusive) to satisfy awards under the Company's share plans and their admission to trading on the Main Market of the London Stock Exchange under the Company's existing block admissions of Shares for this purpose (as detailed in the table below).

This notification covers the period of 19 January 2026 to 27 February 2026 (inclusive).

 

1

Details of the issuer

a)

Name

Lloyds Banking Group plc

b)

LEI

549300PPXHEU2JF0AM85

2

Details of the transferable securities admitted to trading

a)

Name, type and identification code

Ordinary Shares of 10p each

GB0008706128

b)

Regulated market

London Stock Exchange - Main Market

c)

Number of further Shares issued and admitted to trading

220,314,633 (19 January 2026 to 27 February 2026 (inclusive))

(admitted under block admissions dated 2 March 2022, 22 November 2023, 27 November 2024, 22 May 2025, 24 November 2025)

d)

Number of Shares admitted to trading following the further issuance set out in 2 c)

59,029,409,081 (as at close of business on 27 February 2026)

(80,689,090 Unallotted Shares (not yet in issue) remain subject to the block admissions dated 27 November 2024, 22 May 2025 and 24 November 2025) 

e)

Fungibility

Fully fungible with existing ordinary shares

3

Issue and admission details

a)

Dates of issuance and admission

19 January 2026 to 27 February 2026 (inclusive)

(admitted under block admissions dated 2 March 2022, 22 November 2023, 27 November 2024, 22 May 2025, 24 November 2025)

b)

Prospectus information

Not applicable

 

- END -

ENQUIRIES:

 

Investor Relations

Douglas Radcliffe

Group Investor Relations Director

Email: douglas.radcliffe@lloydsbanking.com

 

Group Corporate Affairs

Matt Smith

Head of Media Relations

Email: matt.smith@lloydsbanking.com

 

+44 (0) 20 7356 1571

 

 

 

+44 (0) 7788 352 487

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEQLLFBQXLLBBL
Date   Source Headline
22nd Apr 20266:02 pmRNSTransaction in Own Shares
21st Apr 20266:02 pmRNSTransaction in Own Shares
20th Apr 20265:55 pmRNSTransaction in Own Shares
17th Apr 20265:58 pmRNSTransaction in Own Shares
16th Apr 20266:04 pmRNSTransaction in Own Shares
16th Apr 20269:14 amRNSAdmission to Trading
15th Apr 20265:58 pmRNSTransaction in Own Shares
14th Apr 20265:56 pmRNSTransaction in Own Shares
14th Apr 20264:00 pmRNSFinal Terms
13th Apr 20266:16 pmRNSTransaction in Own Shares
13th Apr 20262:00 pmRNSDirector/PDMR Shareholding
10th Apr 20265:45 pmRNSTransaction in Own Shares
9th Apr 20266:21 pmRNSTransaction in Own Shares
7th Apr 20265:59 pmRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSMotor Finance Update
31st Mar 20265:59 pmRNSTransaction in Own Shares
31st Mar 20264:00 pmRNSTotal Voting Rights
31st Mar 20267:00 amRNSMotor Finance Update
31st Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20265:49 pmRNSTransaction in Own Shares
26th Mar 20265:56 pmRNSTransaction in Own Shares
25th Mar 20266:06 pmRNSTransaction in Own Shares
25th Mar 20269:25 amRNSNotification of Redemption
24th Mar 20266:08 pmRNSTransaction in Own Shares
23rd Mar 20263:33 pmRNSDirector/PDMR Shareholding
23rd Mar 20262:42 pmRNSPublication of a Prospectus
20th Mar 20266:24 pmRNSTransaction in Own Shares
19th Mar 20266:15 pmRNSTransaction in Own Shares
18th Mar 20266:17 pmRNSTransaction in Own Shares
18th Mar 20265:08 pmRNSPublication of Final Terms
18th Mar 20265:06 pmRNSPublication of Final Terms
17th Mar 20265:56 pmRNSTransaction in Own Shares
16th Mar 20266:19 pmRNSTransaction in Own Shares
16th Mar 20262:15 pmRNSDirector/PDMR Shareholding - Replacement
13th Mar 20266:00 pmRNSTransaction in Own Shares
13th Mar 20264:45 pmRNSDirector/PDMR Shareholding
13th Mar 20261:22 pmRNSNotice of AGM
12th Mar 20265:55 pmRNSTransaction in Own Shares
11th Mar 20265:51 pmRNSTransaction in Own Shares
10th Mar 20266:17 pmRNSTransaction in Own Shares
10th Mar 20266:17 pmRNSTransaction in Own Shares
10th Mar 20263:00 pmRNSDirector/PDMR Shareholding
10th Mar 20263:00 pmRNSDirector/PDMR Shareholding
9th Mar 20262:00 pmRNSDirector/PDMR Shareholding
9th Mar 20262:00 pmRNSDirector/PDMR Shareholding
9th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20266:04 pmRNSTransaction in Own Shares
5th Mar 20262:35 pmRNSDirector/PDMR Shareholding
4th Mar 20266:03 pmRNSTransaction in Own Shares
3rd Mar 20266:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.